市场调查报告书

神经补缀的全球市场 - 类型,技术,用途,各地区 - 成长,趋势,及预测(2018年~2023年)

Neuroprosthetics Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品编码 661183
出版日期 内容资讯 英文 120 Pages
商品交期: 2-3个工作天内
价格
Back to Top
神经补缀的全球市场 - 类型,技术,用途,各地区 - 成长,趋势,及预测(2018年~2023年) Neuroprosthetics Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年02月01日内容资讯: 英文 120 Pages
简介

全球神经补缀市场在2018年到2023年间,预测将以约12.4%的年复合成长率增长。神经补缀是一系列装置,可以替代因受伤或疾病而受损的运动,感觉或认知方式的功能。

本报告提供神经补缀的全球市场调查,提供市场概要,类型·技术·用途,各地区的市场趋势,市场规模的变化与预测,市场促进·阻碍因素以及市场机会分析,竞争情形,主要企业的简介等全面性资讯。

目录

第1章 简介

  • 市场定义

第2章 调查方法

第3章 摘要整理

第4章 主要影响要素

第5章 市场概要

  • 目前市场方案
  • 波特的五力分析
    • 供应商谈判力
    • 消费者谈判力
    • 新加入厂商的威胁
    • 替代产品与服务的威胁
    • 产业内的竞争

第6章 成长要素,阻碍因素,机会,课题分析

  • 市场成长要素
  • 市场阻碍因素
  • 市场机会
  • 主要课题

第7章 市场区隔

  • 各类型
    • 输出神经补缀
    • 输入神经补缀
  • 技巧
    • 脊髓电刺激法
    • 脑深部刺激法
    • 迷走神经刺激法
    • 荐椎神经刺激法
    • 经顱磁刺激法
  • 各用途
    • 运动神经原障碍
    • 生理学的疾病
    • 认知障碍
  • 各地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他地区

第8章 竞争情形

  • M&A分析
  • 协定,联盟,伙伴关系
  • 新产品的销售

第9章 主要企业

  • Abbott
  • Boston Scientific
  • Cochlear
  • Livanova
  • Med-El
  • Medtronic
  • NDI Medical
  • Neuropace
  • Nevro
  • Retina Implant
  • Second Sight
  • Sonova

第10章 市场未来展望

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: 60474

People with hearing loss benefit from early identification; use of hearing aids, cochlear implants, and other devices. According to the World Health Organization estimates, around 466 million people worldwide have disabling hearing loss and by 2050 more than 900 million people are expected to suffer from the same. The cochlear implant is the oldest form of neuroprosthetic, which was approved for use by the US Food and Drug Administration (FDA), in 1984. This device proves to be beneficial for people, with deafness, or severely hard-of-hearing. This device can also be used by patients, who have experienced intense hearing loss, caused by disease or injury, allowing them to hear sounds in their environment. Hence, with the increasing incidences of hearing loss, scientists are investing more in novel neuroprosthetics, which will drive the market over the forecast period.

Key Market Trends

Input Neural Prosthetics Segment is Expected to Show Better Growth in the Forecast Years

Based on equipment, it is segmented into input neural prosthetics and output neural prosthetics. The Input neural prosthetics is expected to show better growth. It mainly includes a cochlear Implant and bionic eye/retinal Implant. These are electronic devices that can help to provide a sense of sound to a person, who is profoundly deaf or severely hard-of-hearing. The implant consists of an external portion that sits behind the ear and a second portion that is surgically placed under the skin. In the United States, roughly 58,000 devices have been implanted in adults and 38,000 in children, according to the US Food and Drug Administration. The market for these prosthetics is expected to show better growth, due to the higher number of children born with hearing defects, and the increasing awareness, along with growing research, in the field of neuroprosthetics.

North America Estimated to Hold the Largest Share in the Neuroprosthetics Market

The neuroprosthetics market estimated to hold the largest share in the North America region due to the increasing number of patients suffering from neurological disorders and nerve injury. Additionally, the number of cases, where children are born with hearing defects, is increasing. According to NIDCD (National Institute of Deafness and Other Communication Disorders), about 2 - 3 of every 1,000 children in the country, are born with a detectable level of hearing loss in one or both ears. According to NIH, nearly 188,000 individuals worldwide, are fitted with a cochlear implant. Hence, with the rising acceptance of neuroprosthetic technology, the market is expected to grow in the forecast period.

Competitive Landscape

The global players into the neuroprosthetics market are Abbott Laboratories, Boston Scientific Corporation, Cochlear Limited, Demant A/S, LivaNova PLC, MED-EL, Medtronic PLC, Oticon, Retina Implant AG and Sonova Holding AG.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Number of Patients Suffering from Neurological Disorders and Nerve Injury
    • 4.2.2 Growing Burden of Hearing Loss and Related Defects
  • 4.3 Market Restraints
    • 4.3.1 Availability of Alternative Treatment Options
    • 4.3.2 High Cost of Neuroprosthetics
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 Output Neural Prosthetics
    • 5.1.2 Input Neural Prosthetics
  • 5.2 By Technique
    • 5.2.1 Spinal Cord Stimulation
    • 5.2.2 Deep Brain Stimulation
    • 5.2.3 Vagus Nerve Stimulation
    • 5.2.4 Other Techniques
  • 5.3 By Application
    • 5.3.1 Motor Neuron Disorders
    • 5.3.2 Physiological Disorders
    • 5.3.3 Cognitive Disorders
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 Cochlear Limited
    • 6.1.4 Demant A/S
    • 6.1.5 LivaNova PLC
    • 6.1.6 MED-EL
    • 6.1.7 Medtronic PLC
    • 6.1.8 Oticon
    • 6.1.9 Retina Implant AG
    • 6.1.10 Sonova Holding AG

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top